http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109893652-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d84aa8c4818bda002eded1de6d318389 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 |
filingDate | 2017-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc4dea9d5a01642f18a2ecf2f103ea85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea61cc86ed97c5efb9f1af04f11e2e7f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_033371d32d74f2f635eae9f87882a697 |
publicationDate | 2019-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-109893652-A |
titleOfInvention | Application using TIPE2 gene as target spot in the drug of preparation treatment tumour |
abstract | This application discloses a kind of applications using TIPE2 gene as target spot in the drug of preparation treatment tumour.The application provides a kind of new target spot for the treatment of primary tumor and metastatic tumo(u)r, i.e. TIPE2 gene can not only inhibit the growth of primary tumor, moreover, being able to suppress Nasopharyngeal neoplasms by inhibiting TIPE2 gene expression;Therefore, the drug for the treatment of primary tumor or metastatic tumo(u)r can be prepared using TIPE2 gene as target spot, provide a kind of new scheme and strategy for the targeted drug treatment of tumour. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023092740-A1 |
priorityDate | 2017-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 100.